Abiopharma

New Form SCHEDULE 13G - Nuwellis, Inc. Filed: 2026-01-20 AccNo: 0001535610-26-000012 Size: 9 KB

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Synlogic, Inc. - Common Stock.

NASDAQ traded attribute type Security_Name was changed. Previous value: Synlogic, Inc. - Common Stock. New value: Synlogic, Inc. - Common Stock.

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Synlogic, Inc. - Common Stock.

COLUMN GROUP III GP, LP 🟢 acquired 32.5K shares of Surrozen, Inc./DE (SRZN) at $20.00 Transaction Date: Jan 15, 2026 | Filing ID: 016991

Kutzkey Tim 🟢 acquired 32.5K shares of Surrozen, Inc./DE (SRZN) at $20.00 Transaction Date: Jan 15, 2026 | Filing ID: 016980

Heyman Richard A. 🔴 sold 6.7K shares of Oric Pharmaceuticals, Inc. (ORIC) at $12.00 Transaction Date: Jan 16, 2026 | Filing ID: 000006

New Form SCHEDULE 13G - Lyra Therapeutics, Inc. Filed: 2026-01-20 AccNo: 0001535610-26-000011 Size: 9 KB

Director Gano Kyle 🟡 adjusted position in 36.4K shares (2 derivative) of NEUROCRINE BIOSCIENCES INC (NBIX) at $132.71 ($7.5M) Transaction Date: Jan 16, 2026 | Filing ID: 000002

Elazzouzi Amy 🔴 sold 1.6K shares of Aura Biosciences, Inc. (AURA) at $4.86 Transaction Date: Jan 20, 2026 | Filing ID: 016939

de los Pinos Elisabet 🔴 sold 16.9K shares of Aura Biosciences, Inc. (AURA) at $4.86 Transaction Date: Jan 20, 2026 | Filing ID: 016938

Burns Thomas William 🟡 adjusted position in 275.0K shares (2 derivative) of GLAUKOS Corp (GKOS) at $115.00 ($40.7M) Transaction Date: Jan 08, 2026 | Filing ID: 000002

Esposito Pamela 🟡 adjusted position in 5.5K shares (2 derivative) of Kymera Therapeutics, Inc. (KYMR) at $68.52 Transaction Date: Jan 20, 2026 | Filing ID: 016934

Agenus Inc. - Agenus to Host First 2026 Stakeholder Webcast

ResMed Inc. Daily Stock Update